Abstract
Background
There is no apparent data on the prevalence of maturity-onset diabetes of young (MODY) in adults in Turkey.
Aim
We aimed to define the prevalence in our early-onset diabetes cohort and find the most prevalent types of MODY in this selected group.
Methods
We included 92 patients who were diagnosed with either two types of diabetes under the age of 35 with a strong family history between 2014 and 2020. We excluded patients with low C-peptide levels and any positivity for beta-cell autoimmunity markers. A panel of fourteen genes of MODY was analyzed for each patient with a next-generation sequence analysis method.
Results
The mean age for the diagnosis of diabetes was 27.9±8.0 years, and most of the patients were male (F/M:37/55). The median body mass index was 27 (19–32) kg/m2, while the median HbA1c level was 6.4% (5–17%). Seven patients had eight pathogenic or likely pathogenic variants (7/92; 7.6%) of MODY genes with variants of GCK (MODY 2, n:1), HNF1A (MODY3, n:1), HNF1β (MODY5, n:1), ABCC8 (MODY12, n:2), INS (MODY 10, n:1), HNF4A (MODY 1, n:1), and PDX1 (MODY4, n:1).
Conclusion
Molecular genetic diagnosis of MODY is necessary for optimal follow-up, treatment, prognosis, and genetic counseling because of the close relationship between phenotype and genotype. Even in our small-sample-sized cohort, we were able to detect MODY variants with appropriate patient selection, and we re-evaluated for additional clinical features for the newly diagnosed MODY patients according to their variants, modified their treatment, and screened their first-degree relatives. This result presents that diabetic patients below 35 age, without low C-peptide levels and any positivity for beta-cell autoimmunity markers, must be screened for MODY gene panel for diagnosis and genetic counseling.
Similar content being viewed by others
Data availability
Data is available on request from the authors.
References
Urbanova J, Brunerova L, Broz J. Hidden MODY-looking for a needle in a haystack. Front Endocrinol (Lausanne). 2018;9:355. https://doi.org/10.3389/fendo.2018.00355.
Firdous P, Nissar K, Ali S, Ganai BA, Shabir U, Hassan T, Masoodi SR. Genetic testing of maturity-onset diabetes of the young current status and future perspectives. Front Endocrinol (Lausanne). 2018;9:253. https://doi.org/10.3389/fendo.2018.00253.
Althari S, Gloyn AL. When is it MODY? Challenges in the Interpretation of sequence variants in MODY genes. Rev Diabet Stud. 2015;12(3-4):330–48. https://doi.org/10.1900/RDS.2015.12.330.
Thanabalasingham G, Owen KR. Diagnosis and management of maturity onset diabetes of the young (MODY). Bmj. 2011;343:d6044. https://doi.org/10.1136/bmj.d6044.
Schober E, Rami B, Grabert M, Thon A, Kapellen T, Reinehr T, Holl RW, DP-WIotGWGfPD. Phenotypical aspects of maturity-onset diabetes of the young (MODY diabetes) in comparison with type 2 diabetes mellitus (T2DM) in children and adolescents: experience from a large multicentre database. Diabet Med. 2009;26(5):466–73. https://doi.org/10.1111/j.1464-5491.2009.02720.x.
Porter JR, Rangasami JJ, Ellard S, Gloyn AL, Shields BM, Edwards J, Anderson JM, Shaw NJ, Hattersley AT, Frayling TM, Plunkett M, Barrett TG. Asian MODY: are we missing an important diagnosis? Diabet Med. 2006;23(11):1257–60. https://doi.org/10.1111/j.1464-5491.2006.01958.x.
Ming-Qiang Z, Yang-Li D, Ke H, Wei W, Jun-Fen F, Chao-Chun Z, Guan-Ping D. Maturity onset diabetes of the young (MODY) in Chinese children: genes and clinical phenotypes. J Pediatr Endocrinol Metab. 2019;32(7):759–65. https://doi.org/10.1515/jpem-2018-0446.
Chapla A, Mruthyunjaya MD, Asha HS, Varghese D, Varshney M, Vasan SK, Venkatesan P, Nair V, Mathai S, Paul TV, Thomas N. Maturity onset diabetes of the young in India - a distinctive mutation pattern identified through targeted next-generation sequencing. Clin Endocrinol. 2015;82(4):533–42. https://doi.org/10.1111/cen.12541.
Shields BM, Hicks S, Shepherd MH, Colclough K, Hattersley AT, Ellard S. Maturity-onset diabetes of the young (MODY): how many cases are we missing? Diabetologia. 2010;53(12):2504–8. https://doi.org/10.1007/s00125-010-1799-4.
Naylor R, Johnson AK, del Gaudio D, Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Gripp KW, Mirzaa GM, Amemiya A, editors. In: GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2022. 2018;24.
Fajans SS, Bell GI. MODY: history, genetics, pathophysiology, and clinical decision making. Diabetes Care. 2011;34(8):1878–84. https://doi.org/10.2337/dc11-0035.
Malachowska B, Borowiec M, Antosik K, Michalak A, Baranowska-Jazwiecka A, Deja G, Jarosz-Chobot P, Brandt A, Mysliwiec M, Stelmach M, Nazim J, Peczynska J, Glowinska-Olszewska B, Horodnicka-Jozwa A, Walczak M, Malecki MT, Zmyslowska A, Szadkowska A, Fendler W, Mlynarski W. Monogenic diabetes prevalence among Polish children-summary of 11 years-long nationwide genetic screening program. Pediatr Diabetes. 2018;19(1):53–8. https://doi.org/10.1111/pedi.12532.
Delvecchio M, Mozzillo E, Salzano G, Iafusco D, Frontino G, Patera PI, Rabbone I, Cherubini V, Grasso V, Tinto N, Giglio S, Contreas G, Di Paola R, Salina A, Cauvin V, Tumini S, d'Annunzio G, Iughetti L, Mantovani V, et al. Monogenic diabetes accounts for 6.3% of cases referred to 15 Italian Pediatric Diabetes Centers During 2007 to 2012. J Clin Endocrinol Metab. 2017;102(6):1826–34. https://doi.org/10.1210/jc.2016-2490.
Taneera J, Mussa B, Saber-Ayad M, Dhaiban S, Aljaibeji H, Sulaiman N. Maturity-onset diabetes of the young: an overview with focus on the Middle East. Curr Mol Med. 2017;17(8):549–62. https://doi.org/10.2174/1566524018666180222121158.
Aarthy R, Aston-Mourney K, Mikocka-Walus A, Radha V, Amutha A, Anjana RM, Unnikrishnan R, Mohan V. Clinical features, complications and treatment of rarer forms of maturity-onset diabetes of the young (MODY) - a review. J Diabetes Complicat. 2021;35(1):107640. https://doi.org/10.1016/j.jdiacomp.2020.107640.
Kanthimathi S, Jahnavi S, Balamurugan K, Ranjani H, Sonya J, Goswami S, Chowdhury S, Mohan V, Radha V. Glucokinase gene mutations (MODY 2) in Asian Indians. Diabetes Technol Ther. 2014;16(3):180–5. https://doi.org/10.1089/dia.2013.0244.
Anuradha S, Radha V, Mohan V. Association of novel variants in the hepatocyte nuclear factor 4A gene with maturity onset diabetes of the young and early onset type 2 diabetes. Clin Genet. 2011;80(6):541–9. https://doi.org/10.1111/j.1399-0004.2010.01577.x.
Radha V, Ek J, Anuradha S, Hansen T, Pedersen O, Mohan V. Identification of novel variants in the hepatocyte nuclear factor-1alpha gene in South Indian patients with maturity onset diabetes of young. J Clin Endocrinol Metab. 2009;94(6):1959–65. https://doi.org/10.1210/jc.2008-2371.
Mohan V, Radha V, Nguyen TT, Stawiski EW, Pahuja KB, Goldstein LD, Tom J, Anjana RM, Kong-Beltran M, Bhangale T, Jahnavi S, Chandni R, Gayathri V, George P, Zhang N, Murugan S, Phalke S, Chaudhuri S, Gupta R, et al. Comprehensive genomic analysis identifies pathogenic variants in maturity-onset diabetes of the young (MODY) patients in South India. BMC Med Genet. 2018;19(1):22. https://doi.org/10.1186/s12881-018-0528-6.
Aykut A, Karaca E, Onay H, Goksen D, Cetinkalp S, Eren E, Ersoy B, Cakir EP, Buyukinan M, Kara C, Anik A, Kirel B, Ozen S, Atik T, Darcan S, Ozkinay F. Analysis of the GCK gene in 79 MODY type 2 patients: a multicenter Turkish study, mutation profile and description of twenty novel mutations. Gene. 2018;641:186–9. https://doi.org/10.1016/j.gene.2017.10.057.
Karaca E, Onay H, Cetinkalp S, Aykut A, Goksen D, Ozen S, Atik T, Darcan S, Tekin IM, Ozkinay F. The spectrum of HNF1A gene mutations in patients with MODY 3 phenotype and identification of three novel germline mutations in Turkish Population. Diabetes Metab Syndr. 2017;11(Suppl 1):S491–6. https://doi.org/10.1016/j.dsx.2017.03.042.
Ozsu E, Cizmecioglu FM, Yesiltepe Mutlu G, Yuksel AB, Caliskan M, Yesilyurt A, Hatun S. Maturity onset diabetes of the young due to glucokinase, HNF1-A, HNF1-B, and HNF4-A mutations in a cohort of Turkish children diagnosed as type 1 diabetes mellitus. Horm Res Paediatr. 2018;90(4):257–65. https://doi.org/10.1159/000494431.
Haliloglu B, Abali S, Bugrul F, Celik E, Bas S, Atay Z, Guran T, Turan S, Bereket A. The distribution of different types of diabetes in childhood: a single center experience. J Clin Res Pediatr Endocrinol. 2018;10(2):125–30. https://doi.org/10.4274/jcrpe.5204.
Beysel S, Eyerci N, Pinarli FA, Kizilgul M, Ozcelik O, Caliskan M, Cakal E. HNF1A gene p.I27L is associated with early-onset, maturity-onset diabetes of the young-like diabetes in Turkey. BMC Endocr Disord. 2019;19(1):51. https://doi.org/10.1186/s12902-019-0375-2.
Ateş EA, Üstay Ö, Polat H, Apaydın T, Elbasan O, Yıldırım Ö, Güney Aİ. Genetic and clinical characterization of patients with maturity-onset of diabetes of the young (MODY): identification of novel variations. Balkan Med J. 2021 Sep;38(5):272–7. https://doi.org/10.5152/balkanmedj.2021.20155. PMID: 34462253
Agladioglu SY, Aycan Z, Cetinkaya S, Bas VN, Onder A, Peltek Kendirci HN, Dogan H, Ceylaner S. Maturity onset diabetes of youth (MODY) in Turkish children: sequence analysis of 11 causative genes by next generation sequencing. J Pediatr Endocrinol Metab. 2016;29(4):487–96. https://doi.org/10.1515/jpem-2015-0039.
Yalçıntepe S, Özgüç Çömlek F, Gürkan H, Demir S, Atlı Eİ, Atlı E, Eker D, Tütüncüler Kökenli F. The Application of Next Generation Sequencing Maturity Onset Diabetes of the Young Gene Panel in Turkish Patients from Trakya Region. J Clin Res Pediatr Endocrinol. 2021 Aug 23;13(3):320–31. https://doi.org/10.4274/jcrpe.galenos.2021.2020.0285. Epub 2021 Feb 10. PMID: 33565752; PMCID: PMC8388052
Demirci DK, Darendeliler F, Poyrazoglu S, Al ADK, Gul N, Tutuncu Y, Gulfidan G, Arga KY, Cacina C, Ozturk O, Aydogan HY, Satman I. Monogenic childhood diabetes: dissecting clinical heterogeneity by next-generation sequencing in maturity-onset diabetes of the young. OMICS. 2021 Jul;25(7):431–49. https://doi.org/10.1089/omi.2021.0081. Epub 2021 Jun 25. PMID: 34171966
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no competing interests.
Informed Consent
The Institutional Ethics Committee approved the study protocol, and all subjects signed informed consent forms.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Gökçay Canpolat, A., Keskin, Ç., Aydoğan, B.İ. et al. Maturity-onset diabetes of the young (MODY)-related genetic variants in a Turkish patient cohort with early-onset diabetes: a cross-sectional study. Int J Diabetes Dev Ctries 43, 244–251 (2023). https://doi.org/10.1007/s13410-022-01052-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13410-022-01052-9